Molecular alterations in basal cell carcinoma subtypes
A number of genes have been implicated in the pathogenesis of BCC in addition to the Hedgehog pathway, which is known to drive the initiation of this tumour. We performed in-depth analysis of 13 BCC-related genes ( CSMD1, CSMD2, DPH3 promote r, PTCH1, SMO, GLI1, NOTCH1, NOTCH2, TP53, ITIH2, DPP10, S...
Saved in:
| Published in: | Scientific reports Vol. 11; no. 1; pp. 13206 - 9 |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
London
Nature Publishing Group UK
24.06.2021
Nature Publishing Group Nature Portfolio |
| Subjects: | |
| ISSN: | 2045-2322, 2045-2322 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | A number of genes have been implicated in the pathogenesis of BCC in addition to the Hedgehog pathway, which is known to drive the initiation of this tumour. We performed in-depth analysis of 13 BCC-related genes (
CSMD1, CSMD2, DPH3
promote
r, PTCH1, SMO, GLI1, NOTCH1, NOTCH2, TP53, ITIH2, DPP10, STEAP4, TERT
promoter) in 57 BCC lesions (26 superficial and 31 nodular) from 55 patients and their corresponding blood samples.
PTCH1
and
TP53
mutations were found in 71.9% and 45.6% of BCCs, respectively. A high mutation rate was also detected in
CSMD1
(63.2%),
NOTCH1
(43.8%) and
DPP10
(35.1%), and frequent non-coding mutations were identified in
TERT
(57.9%) and
DPH3
promoter (49.1%).
CSMD1
mutations significantly co-occurred with
TP53
changes (
p
= 0.002). A significant association was observed between the superficial type of BCC and
PTCH1
(
p
= 0.018) and
NOTCH1
(
p
= 0.020) mutations. In addition,
PTCH1
mutations were significantly associated with intermittent sun exposure (
p
= 0.046) and the occurrence of single lesions (
p
= 0.021), while
NOTCH1
mutations were more frequent in BCCs located on the trunk compared to the head/neck and extremities (
p
= 0.001). In conclusion, we provide further insights into the molecular alterations underlying the tumorigenic mechanism of superficial and nodular BCCs with a view towards novel rationale-based therapeutic strategies. |
|---|---|
| Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ISSN: | 2045-2322 2045-2322 |
| DOI: | 10.1038/s41598-021-92592-3 |